{"id":"W3174239144","doi":"10.1111/jdv.17486","title":"Three‐year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial","year":2021,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Placebo; Randomized controlled trial; Etanercept; Internal medicine; Plaque psoriasis; Open label; Surgery; Psoriasis; Dermatology; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005637494,0.001487003,0.002299199,0.0003202424,0.0005644934,0.001608448,0.0008822175,0.001862191,0.004373636],"category_scores_gemma":[0.004105718,0.0005360071,0.00339614,0.000465274,0.0009910672,0.001039378,0.0004718301,0.003823289,0.0007709938],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009430916,"about_ca_system_score_gemma":0.001514029,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009854584,"about_ca_topic_score_gemma":0.001408169,"domain_scores_codex":[0.9982534,0.001010672,0.0001168102,0.0002183498,0.0001970981,0.0002036116],"domain_scores_gemma":[0.9973911,0.0007173955,0.0008783987,0.0002987353,0.0001723363,0.0005420179],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9798448,0.00267644,0.001764596,0.0003988282,0.001774496,0.00004076708,0.00004786945,0.0002973255,0.001191894,0.00007094116,0.001114221,0.01077783],"study_design_scores_gemma":[0.9560972,0.0329853,0.00776729,0.00005551119,0.001502798,0.00006449773,0.00002256668,0.0003000924,0.0003741865,0.0001621596,0.0006496269,0.00001875888],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9798733,0.01025011,0.0007919208,0.001131479,0.000455369,0.00252151,0.00235515,0.0001138573,0.002507352],"genre_scores_gemma":[0.9857574,0.003628839,0.0009775149,0.001362484,0.0005625228,0.003328563,0.002901834,0.00004042431,0.001440306],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005637494,"threshold_uncertainty_score":0.0298143,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03394214723082044,"score_gpt":0.2879030609756602,"score_spread":0.2539609137448398,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}